We used phosphorous-31 nuclear magnetic resonance spectroscopy in a rat model of 10 minutes' severe incomplete forebrain ischemia (two-vessel occlusion with hypotension) to study the effects of preischemic and postischemic treatment with 3 mg/kg i.v. U74006F on the recovery of high-energy phosphates and intracellular pH during early reperfusion. The mean±SD time to 85% recovery of phosphocreatine was 14.1 ±8.4 minutes in the control group (n=10) compared with 6.6±3.5 minutes (p<0.05) in the preischemic (n=8) and 4.2±1.0 minutes (/?<0.001) in the postischemic (n=ll) treatment groups. The mean±SD time to 80% recovery of adenosine triphospbate was 15.4 ±8.5 minutes in the control group compared with 6.3±1.8 (p<0.005) and 5.4±2.8 ( p < 0 M l ) minutes in the preischemic and postischemic treatment groups, respectively. There were no differences in intracellular pH between the control and either of the treatment groups. We conclude that U74006F led to quicker recovery of high-energy phosphates during early reperfusion, and this beneficial effect was also seen with postischemic treatment (Stroke 1991;22:1188-1192) O xygen free radicals are difficult to detect in vivo, but some studies have indicated an increased production after cerebral ischemia.
O xygen free radicals are difficult to detect in vivo, but some studies have indicated an increased production after cerebral ischemia. 1 -8 One target of oxygen free radicals is lipid peroxidation, with consequent membrane damage.
9
U74006F is a nonglucocorticoid 21-aminosteroid that in vitro has been found to inhibit strongly ironcatalyzed lipid peroxidation, 10 to scavenge lipid peroxyl radicals in a manner similar to that of vitamin E, 11 and to block the release of arachidonic acid from iron-exposed cell membranes. 12 With preischemic treatment with U74006F in animal models of transient ischemia and reperfusion have been found a sparing in brain tissue of the naturally occurring free radical scavenger vitamin E and quicker restoration of extracellular calcium after ischemia, 13 better longterm neuronal survival, 14 and improved neurological outcome.
1S Even postischemic treatment was found to improve neurological outcome 16 and to attenuate delayed hypoperfusion and improve the recovery of evoked potentials. 17 In animal models of focal ischemia postischemic treatment with U74006F de-creased infarct size 18 and reduced edema in the penumbra zone. 19 We investigated the immediate effect of U74006F on acidosis and energy state during early reperfusion after transient ischemia. We used phosphorous-31 nuclear magnetic resonance ( 31 P NMR) spectroscopy to measure intracellular pH, phosphocreatine (PCr), and adenosine triphosphate (ATP) continuously in vivo during and after 10 minutes of severe incomplete forebrain ischemia in rats (two-vessel occlusion with hypotension 20 ). The effect of preischemic and postischemic treatment with U74006F on the recovery of these parameters during the first half hour of reperfusion was compared with recovery in a control group.
Materials and Methods
We have described our experimental model in detail. 21 Male Wistar rats weighing 300-330 g were fasted overnight, anesthetized with halothane, tracheotomized, and connected to a respirator. After 30 minutes of surgery, the halothane was discontinued and the rats were kept on 70% nitrous oxide and 30% oxygen and given a single dose of 0.2 mg i.v. pancuronium and 0.1 mg i.v. buprenorphine. The rats rested 30 minutes before the start of ischemia.
Cerebral ischemia was induced by combined bilateral carotid artery occlusion and systemic blood pressure reduction to 40-50 mm Hg through exsanguination. After 10 minutes of ischemia, the snares around the carotid arteries were removed and the shed blood was reinfused to return blood pressure to normal. The rats were given 1.0 mmol NaHCO 3 during the first 3 minutes of reperfusion. The temperature of the head was regulated independently, and intracerebral temperature was kept constant around 36.5°C throughout the experiment and during ischemia by blowing hot air into the rat chamber. Brain temperature was measured continuously in a pilot study with a temperature probe placed in the cerebral tissue through a burr hole in the skull. We made similar measurements after 30 minutes of reperfusion in the present study. Arterial blood pressure was monitored throughout the experiment and stayed above 110 mm Hg before and after ischemia. Arterial blood samples were taken at fixed intervals to measure blood pH, Paco 2 , Pac>2, base excess, and serum glucose.
A vertical-bore 4.7-T/200-MHz Bruker MSL 200 spectrometer (Billerica, Mass.) was used; 31 P NMR spectra were acquired with an oval surface coil of 13 and 16 mm diameters placed directly on the exposed skull. A pulse width of 15 /isec was found to give the best signal-to-noise ratio, and the repetition time was 1 second. The broad baseline signal was removed using the convolution-difference method, and this was done in three consecutive repetitions with an exponential function of line broadening of 800 Hz to minimize distortions of the peak areas. The free induction decays were Fourier-transformed after filtering with a 30-Hz exponential function. Phasecorrection was done visually in the first preischemic spectrum and copied in all spectra of a given rat.
Intracellular pH was calculated from the shift between the peaks for inorganic phosphate and PCr using the formula 22 pH=6.77 + log[(shift-3.29)/ (5.68-shift)]. PCr during ischemia was assigned a shift value through interpolation between the averages of the values immediately before and after ischemia.
The PCr and /3-ATP peaks were quantified with area measurements, and the results are presented as the ratios PCr/PCr 0 and ATP/ATP,,, where PCr 0 and ATP 0 are baseline values for each rat calculated independently from two 4-minute acquisitions immediately prior to ischemia. The baseline for the PCr peak was drawn visually as one continuous line from an overlay plot of all spectra from a given rat. The baseline for the /3-ATP peak was drawn by the computer individually in each spectrum between the average of the noise adjacent to the peak on each side. The peak areas were computer-integrated without any curve-fitting procedure. For ATP the height of the peaks was also measured (data not shown). The time during reperfusion to 85% recovery of PCr and 80% recovery of ATP was estimated from peak area measurements in each rat.
Intracellular pH was calculated from 1-minute acquisitions during ischemia and the first 5 minutes of reperfusion. All other values were calculated from 4-minute acquisitions. Some of these were summed from 1-minute acquisitions with a delay of 1 minute between each (1+2+3+4, 2+3+4+5, 3+4+5+6, etc.). This procedure was found to give additional information by improving the temporal profile of the quick changes, but it increases the number of statistical comparisons done on the same experimental information.
After the second minute of ischemia small peaks for PCr and ATP could still be distinguished in some of the 4-minute acquisition spectra. We do not know to what extent this was due to the presence of small amounts of nonischemic tissue in the field of the surface coil or to the preservation of high-energy phosphates in the ischemic forebrain. 23 The sizes of these peaks were steady for the rest of the ischemic period, and there were no differences between groups during ischemia. Quantification of small peaks in biological NMR spectra is difficult due to contributions from baseline inaccuracies and overlapping noise. The calculated ratios during ischemia represent a definite overestimation of the actual amounts of high-energy phosphates present during this phase. We decided not to present the results during ischemia because they would be misleading for the interpretation of recovery during reperfusion.
There were three experimental groups: control (« = 10), preischemic treatment with 3 mg/kg i.v. U74006F (n=8), and postischemic treatment with 3 mg/kg i.v. U74006F («=11). Preischemic treatment was given as a 5-minute bolus 10 minutes prior to ischemia, and postischemic treatment was given as a single bolus during the first minute of reperfusion. Vehicle supplied by the Upjohn Co. (Kalamazoo, Mich.) was injected in equal amounts at the same time points in the other groups.
Altogether, 42 rats from the same shipment entered the study in a strict protocol, and the experiments were performed on 10 consecutive days. Three rats were excluded because of a sudden decrease in blood pressure during early reperfusion, and they all belonged to the preischemic treatment group. The other 10 exclusions (four, three, and three rats in the control, preischemic treatment, and postischemic treatment groups, respectively) were all due to technical problems. Accordingly, 29 rats were included. The controls and each treatment group were compared by using one-way analysis of variance and subsequent Fisher's least significant difference multiple comparison test at probability levels of 0.05, 0.005, and 0.001.
Results
Data for general physiological and biochemical parameters are presented in Table 1 . There were no significant differences between groups for any measured parameter. All rats showed a tendency to decreased Paco 2 , increased metabolic acidosis, and decreased serum glucose after ischemia.
The results for PCr are presented in Figure 1 . Within the recorded 30 minutes of reperfusion PCr recovered to around 95% of the preischemic level in the two treatment groups and to around 85% in the Figure 2 . Within the recorded 30 minutes of reperfusion ATP recovered to around 90% of the preischemic level in the two treatment groups and to around 80% in the control group. Estimated from peak area measurements, the time during reperfusion to 80% recovery was 15 controls was significant at/?<0.05 for minutes 11-17 of reperfusion. The difference between the postischemic treatment group and the controls was significant at/?<0.05 for minutes 2, 3, and 13-17 of reperfusion.
The results for intracellular pH are presented in Figure 3 . In all three groups there was a decrease during ischemia to a steady level around pH 6.55. The recovery of intracellular pH after ischemia leveled out after approximately 15 minutes, with values slightly lower than the preischemic pH, around 7.15. There was no difference between the controls and either treatment group during ischemia and reperfusion except at 4 minutes of reperfusion.
Discussion
The recovery of PCr during early reperfusion was quicker in both groups treated with U74006F than in the control group. The data for ATP were more uncertain due to the problems of quantification of these peaks in biological NMR spectra. Especially during the first minutes of reperfusion, the /8-ATP peaks had distorted shapes. This was partly a result of biological conditions, with summation of peak components with different shapes and shift values due to locally heterogeneous pH and ion concentrations. Computer-integrated areas of peaks with no curve-fitting procedure should accordingly be the best representation of the true concentrations. This method has, however, additional sources of error due to inaccuracies in the outer limits of the peak areas. However, in all groups the mean peak heights (data not shown) were found to be in good accordance with the area measurements. The main exception was during the first 2 minutes of reperfusion, when there was a small but uniform underestimation of peak heights. Because of smaller standard deviations in the peak height measurements, the differences between groups were more convincingly significant. Furthermore, the differences in the time during reperfusion to 80% recovery of ATP were clearly significant when based on peak area measurements, and our conclusion was that the recovery of ATP during early reperfusion was quicker in the two groups treated with U74006F than in the control group. Recovery of high-energy phosphates during reperfusion is not a reliable predictor of final neuronal survival or functional outcome. It is probable that ATP can initially recover in cells with irreversible damage and that events at later stages during reperfusion have an impact on the final outcome. However, the quicker early recovery with treatment with U74006F suggests an immediate beneficial effect of the drug on brain tissue during the first 30 minutes of reperfusion. • Y JIMH^\ Almost all ATP in the brain is generated in the mitochondria. 24 It is, however, not possible to conclude that the improved recovery of ATP with U74006F in this study was due to a direct effect on the mitochondria. The mechanism of action could as well be improved microcirculation, which has been proposed by some authors to be the main target of free radical damage during reperfusion after cerebral ischemia. 25 -26 The quicker recovery of high-energy phosphates was also found when U74006F was injected after the ischemic insult. This is in accordance with the concept of free radical damage as a reperfusion injury when oxygen returns to brain tissue after ischemia. 9 The results gave the impression that postischemic treatment was even better than preischemic treatment. However, the study did not allow for any comparison between the two treatment groups. Drug concentrations were not measured, and in the preischemic treatment group there was a 20-minute period between the injection of U74006F and the start of reperfusion. Furthermore, the systemic hypotension during ischemia in this rat model may produce free radicals in tissues other than the brain. And, because U74006F is degraded when reacting with peroxyl radicals, 11 the amount of drug available at the start of reperfusion could have been considerably reduced in the preischemic treatment group.
We conclude that recovery of high-energy phosphates during early reperfusion after 10 minutes of forebrain ischemia in rats was quicker with U74006F treatment. This beneficial effect was also found with postischemic treatment. U74006F was not found to have any effect on intracellular pH during ischemia or early reperfusion.
